News and Events

The Institute for Therapeutics Discovery and Development (ITDD) has been awarded a new NIH contract entitled "Support for NCATS Medicinal Chemistry for Lead Optimization". The objective of this contract is to support the NIH National Center for Advanced Translational Sciences (NCATS) drug development programs by identifying preclinical drug candidates with improved efficacy, optimized ADME properties, and minimal predicted toxicity. The potential value of this five-year contract is $17,887,012. The program is led by Dr. Vadim J.

Gunda Georg, PhD, has been appointed a Regents Professor of the University of Minnesota. The Regents Professorship is the highest honor the University bestows on its faculty. It recognizes faculty who have made exceptional contributions to the University through teaching, research, scholarship, or creative work, and contributions to the public good.

Gunda Georg is featured in the WCCO-TV story, "'U' Chemists Close To Making


Gunda Georg was featured in several stories on her work to develop a male birth control pill

Gunda Georg was featured in a KARE-11 story and in 

Gunda Georg and Shameem Syeda were featured on the front page of the Star

Gunda Georg's research was featured in ACS in the News: Potential Male Birth Control Pill has Deadly Origins.  Click here to read more.


Rebecca Cuellar and Gunda Georg are featured in the MN Daily story, "Heart-stopping poison could be a promising male birth control, UMN study shows." Georg is also featured in The Student Newspaper story, "Will male contraception be derived from Cupid's arrow?" and The Futurist story, "The Future of


Gunda Georg, Jon Hawkinson and Shameem Syeda are featured in the Smithsonian Magazine and The Daily Caller for their research to develop a birth control pill for men that has its origin in an arrow poison. 


Will blue packets replace pink ones soon? After decades of research, development of a male birth control may now be one step closer.